A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan
暂无分享,去创建一个
Y. Kameyoshi | T. Hiragun | M. Hide | S. Takahagi | A. Tanaka | S. Mihara | H. Shindo | K. Iwamoto | Toshihiko Tanaka | K. Furutani | R. Saito | T. Numata | M. Hiragun | N. Niimi | Fumiko Nakano
[1] J. Multmeier,et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] T. Zuberbier,et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria , 2021, Allergy.
[3] T. Zuberbier,et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis , 2020, Allergy.
[4] T. Nakahara,et al. Real-world clinical practices for spontaneous urticaria and angioedema in Japan: A nation-wide cross-sectional web questionnaire survey. , 2019, Allergology international : official journal of the Japanese Society of Allergology.
[5] F. Bérard,et al. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU , 2018, Allergy.
[6] M. Hide,et al. Impact of chronic urticaria on quality of life and work in Japan: Results of a real‐world study , 2018, The Journal of dermatology.
[7] J. Seo,et al. Epidemiology of urticaria including physical urticaria and angioedema in Korea , 2018, The Korean journal of internal medicine.
[8] T. Jakob,et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence , 2017, The Journal of allergy and clinical immunology.
[9] Soichiro Matsushima,et al. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria. , 2017, Journal of dermatological science.
[10] J. Bousquet,et al. Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence , 2016, Allergy.
[11] J. Bernstein,et al. Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines , 2015, Current Allergy and Asthma Reports.
[12] J. Bousquet,et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.
[13] T. Zuberbier,et al. Epidemiology of urticaria: a representative cross‐sectional population survey , 2010, Clinical and experimental dermatology.
[14] S. Jiamton,et al. Chronic idiopathic urticaria: prevalence and clinical course , 2007, The Journal of dermatology.
[15] Y. Kameyoshi,et al. [Analysis of the prevalence of subtypes of urticaria and angioedema]. , 2006, Arerugi = [Allergy].
[16] G. Canonica,et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy , 2003, Allergy.
[17] E. Nettis,et al. Clinical and aetiological aspects in urticaria and angio-oedema , 2003 .
[18] P M Bossuyt,et al. Natural course of physical and chronic urticaria and angioedema in 220 patients. , 2001, Journal of the American Academy of Dermatology.
[19] Humphreys,et al. The characteristics of urticaria in 390 patients , 1998, The British journal of dermatology.